Cargando…

Insights from the molecular docking analysis of gambogic acid with the Chikungunya spike glycoprotein E2

Chikungunya fever is a mosquito-borne disease caused by the chikungunya virus (CHIKV) and has drawn substantial attention in recent years. So far, no effective treatment is available in the form of drugs or vaccines. In this study, we aimed to screen some drugs against the pathogenic Chikungunya vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qamar, Sadia, Syeda, Amna, Amjad Beg, M, Irfan Qureshi, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599661/ https://www.ncbi.nlm.nih.gov/pubmed/37886138 http://dx.doi.org/10.6026/97320630019525

Ejemplares similares

Peptide vaccine against chikungunya virus: immuno-informatics combined with molecular docking approach
por: Tahir ul Qamar, Muhammad, et al.
Publicado: (2018)

A Gamboge Case
por: Biegler, J. A.
Publicado: (1887)

Molecular docking analysis of azithromycin and hydroxychloroquine with spike surface glycoprotein of SARS-CoV-2
por: Singh, Jitender, et al.
Publicado: (2021)

Insights from molecular structure predictions of the infectious bronchitis virus S1 spike glycoprotein
por: Leyson, Christina Lora M., et al.
Publicado: (2016)

Functional processing and secretion of Chikungunya virus E1 and E2 glycoproteins in insect cells
por: Metz, Stefan W, et al.
Publicado: (2011)

Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking
por: Yu, Ran, et al.
Publicado: (2022)

Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin
por: Bhanu, Piyush, et al.
Publicado: (2020)

Clinical Spectrum of Chikungunya in Pakistan
por: Naqvi, Syeda, et al.
Publicado: (2017)

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
por: Chen, Tao, et al.
Publicado: (2012)

Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins
por: Quiroz, Jose A., et al.
Publicado: (2019)

Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies
por: Mora Lagares, Liadys, et al.
Publicado: (2020)

Molecular Docking Analysis of Anti-Severe Acute Respiratory Syndrome-Coronavirus 2 Ligands against Spike Glycoprotein and the 3-Chymotrypsin-Like Protease
por: Janabi, Ali Hassan Daghir
Publicado: (2021)

A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases
por: Pushkaran, Anju Choorakottayil, et al.
Publicado: (2021)

Docking and Molecular Dynamics Simulations Clarify Binding Sites for Interactions of Novel Marine Sulfated Glycans with SARS-CoV-2 Spike Glycoprotein
por: Samanta, Priyanka, et al.
Publicado: (2023)

Glycoprotein molecular dynamics analysis: SARS-CoV-2 spike glycoprotein case study
por: Coutinho, João Victor Paccini, et al.
Publicado: (2022)

Epistatic Roles of E2 Glycoprotein Mutations in Adaption of Chikungunya Virus to Aedes Albopictus and Ae. Aegypti Mosquitoes
por: Tsetsarkin, Konstantin A., et al.
Publicado: (2009)

Gambogic Acid and Its Analogs Inhibit Gap Junctional Intercellular Communication
por: Choi, Eun J., et al.
Publicado: (2018)

Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations
por: Dhameliya, Tejas M., et al.
Publicado: (2022)

mRNA Vaccine Designing Using Chikungunya Virus E Glycoprotein through Immunoinformatics-Guided Approaches
por: Jaan, Samavia, et al.
Publicado: (2022)

Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2017)

Gambogic acid suppresses colon cancer cell activity in vitro
por: Zhou, Zailong, et al.
Publicado: (2019)

Gambogic Acid as a Candidate for Cancer Therapy: A Review
por: Liu, Yuling, et al.
Publicado: (2020)

Chikungunya virus glycoproteins transform macrophages into productive viral dissemination vessels
por: Yao, Zhenlan, et al.
Publicado: (2023)

Molecular Docking Studies with Rabies Virus Glycoprotein to Design Viral Therapeutics
por: Tomar, N. R., et al.
Publicado: (2010)

The rubella virus E2 and E1 spike glycoproteins are targeted to the Golgi complex
Publicado: (1993)

Molecular docking analysis of p53 with Toll-like receptors
por: Alam, Mohammad Jahoor, et al.
Publicado: (2021)

Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (M(pro)) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study
por: Tallei, Trina Ekawati, et al.
Publicado: (2020)

Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology
por: Hossain, Md Arju, et al.
Publicado: (2023)

Molecular and phylogenetic analysis of bovine coronavirus based on the spike glycoprotein gene
por: Martínez, Nadia, et al.
Publicado: (2012)

Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein
por: Spiga, Ottavia, et al.
Publicado: (2003)

Molecular Modeling and Docking Study to Elucidate Novel Chikungunya Virus nsP2 Protease Inhibitors
por: Agarwal, T., et al.
Publicado: (2015)

POSB422 Machine Learning-Based Virtual Screening, Molecular Docking and Drug-Likeness to Discover New Inhibitors of the Glycoprotein Spike (S1) of SARS-CoV-2
por: Cobre, AF, et al.
Publicado: (2022)

Inflammation, fibrosis and E1 glycoprotein persistence in joint tissue of patients with post-Chikungunya chronic articular disease
por: de Brito, Maíra Sant Anna Genaro, et al.
Publicado: (2023)

Screening of cryptogamic secondary metabolites as putative inhibitors of SARS-CoV-2 main protease and ribosomal binding domain of spike glycoprotein by molecular docking and molecular dynamics approaches
por: Prateeksha, G., et al.
Publicado: (2021)

Molecular Docking Based Screening of Plant Flavonoids as Dengue NS1 Inhibitors
por: Qamar, Muhammad Tahir ul, et al.
Publicado: (2014)

Structural Optimization and Improving Antitumor Potential of Moreollic Acid from Gamboge
por: Cheng, Li-Zhi, et al.
Publicado: (2022)

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs
por: Li, Meng, et al.
Publicado: (2022)

Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid
por: Li, Mingzhu, et al.
Publicado: (2022)

Gambogic acid and juglone inhibit RNase P through distinct mechanisms
por: Wu Meyers, Nancy, et al.
Publicado: (2022)

Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate
por: Jitrangsri, Kritamorn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_clm5tlnlikb62b1uiq7g9f060r